Refocus Group Inc RFCS:Grey Market

*Data is delayed | Exchange | USD
Last | 02/23/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date03/30/23
  • 52 Week Low0.00
  • 52 Week Low Date02/23/24

Key Stats

  • Market Cap24.669
  • Shares Out24.67M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-0.12
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date03/30/23
  • 52 Week Low0.00
  • 52 Week Low Date02/23/24
  • Market Cap24.669
  • Shares Out24.67M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-0.12
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.42M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Refocus Group Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Refocus Group, Inc. is a medical device company. The Company is involved in researching and developing treatments for human vision disorders, particularly for the treatment of presbyopia. The Company’s product, VisAbility Micro Insert System, is a binocular presbyopia treatment, which works outside the visual axis. VisAbility Micro Insert System is under clinical trials in the United States and aims to help patients reduce or eliminate their need for reading glasses.
Glen Bradley Ph.D.
Chairman of the Board
Douglas Williamson
President, Chief Executive Officer, Director
Zack Thompson
Chief Financial Officer, Senior Vice President of Business Development
Mark Cox
Chief Financial Officer, Chief Technology Officer, Secretary
Address
9155 Sterling Street, Suite 160
Irving, TX
75063
United States